ACADIA Pharmaceuticals
ACAD
#3635
Rank
โ‚ฌ3.06 B
Marketcap
17,99ย โ‚ฌ
Share price
-3.35%
Change (1 day)
13.03%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): โ‚ฌ0.12 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ1.07 Billion. a decrease over its 2024 earnings that were of โ‚ฌ0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.12 B-46.18%
2024 โ‚ฌ0.22 B-605.67%
2023 -โ‚ฌ44.25 Million-76.09%
2022 -โ‚ฌ0.19 Billion27.41%
2021 -โ‚ฌ0.15 Billion-40.38%
2020 -โ‚ฌ0.25 Billion19.88%
2019 -โ‚ฌ0.21 Billion-3.92%
2018 -โ‚ฌ0.22 Billion-15.04%
2017 -โ‚ฌ0.25 Billion6.33%
2016 -โ‚ฌ0.24 Billion64.55%
2015 -โ‚ฌ0.15 Billion77.47%
2014 -โ‚ฌ80.17 Million143.69%
2013 -โ‚ฌ32.9 Million81.93%
2012 -โ‚ฌ18.09 Million-8.73%
2011 -โ‚ฌ19.82 Million-251.39%
2010 โ‚ฌ13.08 M-133.2%
2009 -โ‚ฌ39.42 Million-30.82%
2008 -โ‚ฌ56.98 Million6.43%
2007 -โ‚ฌ53.54 Million25.89%
2006 -โ‚ฌ42.53 Million36.99%
2005 -โ‚ฌ31.05 Million37.22%
2004 -โ‚ฌ22.63 Million19.96%
2003 -โ‚ฌ18.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ29.08 B 24,054.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ8.83 B 7,237.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ22.30 B 18,424.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.08 B 6,615.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-โ‚ฌ0.11 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-โ‚ฌ33.49 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA